Shandong Xinhua Pharmaceutical Company Limited - Asset Resilience Ratio

Latest as of December 2016: 0.64%

Shandong Xinhua Pharmaceutical Company Limited (XIN) has an Asset Resilience Ratio of 0.64% as of December 2016. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shandong Xinhua Pharmaceutical Company L (XIN) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€30.00 Million

≈ $35.07 Million USD Cash + Short-term Investments

Total Assets

€4.72 Billion

≈ $5.52 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2016)

This chart shows how Shandong Xinhua Pharmaceutical Company Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Shandong Xinhua Pharmaceutical Company L's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down Shandong Xinhua Pharmaceutical Company Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Shandong Xinhua Pharmaceutical Company L strategic investment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€30.00 Million	0.64%
Total Liquid Assets	€30.00 Million	0.64%

Asset Resilience Insights

Limited Liquidity: Shandong Xinhua Pharmaceutical Company Limited maintains only 0.64% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shandong Xinhua Pharmaceutical Company Limited Industry Peers by Asset Resilience Ratio

Compare Shandong Xinhua Pharmaceutical Company Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	0.50%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Neuland Laboratories Limited NSE:NEULANDLAB	Drug Manufacturers - Specialty & Generic	9.65%
China Resources Double-Crane Pharmaceutical Co Ltd SHG:600062	Drug Manufacturers - Specialty & Generic	1.18%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%

Annual Asset Resilience Ratio for Shandong Xinhua Pharmaceutical Company Limited (2016–2016)

The table below shows the annual Asset Resilience Ratio data for Shandong Xinhua Pharmaceutical Company Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2016-12-31	0.64%	€30.00 Million ≈ $35.07 Million	€4.72 Billion ≈ $5.52 Billion	--

pp = percentage points

About Shandong Xinhua Pharmaceutical Company Limited

F:XIN Germany Drug Manufacturers - Specialty & Generic

Market Cap

$131.09 Million

€112.12 Million EUR

Market Cap Rank

#18246 Global

#1697 in Germany

Share Price

€0.58

Change (1 day)

-0.86%

52-Week Range

€0.57 - €0.84

All Time High

€0.97